Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: May 16, 2019
Open Peer Review Period: May 21, 2019 - Jul 16, 2019
Date Accepted: Jun 15, 2020
Date Submitted to PubMed: Sep 15, 2020
(closed for review but you can still tweet)
mHealth and Opportunities in Anti-Retroviral Adherence in HIV, A Diverse Group of Patients with Diverse and Unique Opportunities: A Narrative Review
ABSTRACT
Background:
Introduction: Antiretrovirals (ARVs) are key in the management of human immunodeficiency virus (HIV). While no cure exists, ARVs help patients live healthy lives and prevent transmission to others. However, medication adherence to sometimes complex drug regiments is paramount to avoid the emergence of a drug-resistant virus. The goal of therapy is to reach an undetectable viral load. However, adherence is a common problem, stemming from such issues as mental health, chaotic home situations and busy work schedules. mHealth represents a new approach to improve medication adherence and multiple studies have been performed in this area.
Objective:
No current objective is listed in abstract. If needed can add the following:
Objective:
Our paper reviews the current implementations of mHealth in the management of HIV within different groups of patients.
Methods:
Methods:
We used the PubMed database using various search terms to review the current implementations of mHealth in HIV care. Titles and abstracts were screened and 37 articles were fully reviewed.
Results:
Results:
Upon a review of the literature, evidence was found for developing nations, intravenous and illicit drug users, and men who have sex with men.
Conclusions:
Discussion: There seems to be a role in developing nations; however, the optimal design of the interventions needs to be delineated. The evidence is less clear in other groups. Clinical Trial: Not Applicable
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.